Search results
Pfizer stock climbs as first quarter earnings, revenue come ahead of estimates By Investing.com
Investing.com· 2 days agoPfizer stock climbs as first quarter earnings, revenue come ahead of estimates
My Top 5 Favorite High-Yield Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 20 hours agoThe company has a strong balance sheet with solid credit ratings. It's also investing in building...
The Motley Fool: Pfizer offers a pfat 6.4% dividend
Dallas Morning News· 5 days agoShares of Pfizer were recently down more than 35% over the past year — in part because the market’s enthusiasm for its COVID-19 vaccine Comirnaty and...
US FDA approves Pfizer's gene therapy for rare bleeding disorder
Reuters via AOL· 7 days ago(Reuters) -The U.S. Food and Drug Administration approved Pfizer's gene therapy for hemophilia B on...
Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 7 days agoBeyond analysts' top -and-bottom-line estimates for Pfizer (PFE), evaluate projections for some of...
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Benzinga via Yahoo Finance· 6 days agoFriday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate...
Pfizer revenues fall 19% due to lower COVID-related product demand
Proactive Investors· 2 days agoPfizer reported a diluted earnings per share of $0.55, with an adjusted figure of $0.82, reflecting...
3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street
Motley Fool via Yahoo Finance· 5 days agoHowever, such stocks exist. Here are three high-yield dividend stocks that could soar 22% to 49%...
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
Motley Fool via Yahoo Finance· 3 days agoI owned shares of Pfizer (NYSE: PFE) when the COVID-19 pandemic started. Watching the stock soar...
US FDA grants full approval for Pfizer's cervical cancer drug
AOL· 3 days agoThe treatment, Tivdak - an antibody-drug conjugate co-developed by Genmab A/S and Seagen - received the FDA's accelerated approval for the same indication in 2021. It was added to Pfizer ...